NL-OMON25575CompletedNot Applicable
A randomized, four-way crossover, comparative bio-availability study of branded (Neurontin®) and three generic 800 mg gabapentin tablets in healthy subjects under fasting conditions.
Maastricht University Medical Center +P.O. Box 58006202 AZ MaastrichtThe NetherlandsTel: 043 388 1766Fax: 043 367 09160 sites24 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Subject candidates must fulfill all of the following inclusion criteria to be eligible for participation in the study, unless otherwise specified:
- •1. Male or female volunteers, 18-55 years of age;
Exclusion Criteria
- •Subject candidates must not be enrolled in the study if they meet any of the following criteria:
- •1. History or presence of significant cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease;
Investigators
Similar Trials
Completed
Not Applicable
A randomized, four-way crossover, comparative bio-availability study of branded (Neurontin®) and three generic 800 mg gabapentin labels in healthy subjects under fasting conditions.epilepsieneuropatic pain10034606epilepsyNL-OMON35125Medisch Universitair Ziekenhuis Maastricht24
Completed
Phase 1
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy VolunteersHypoglycemiaNCT00745186Hospira, now a wholly owned subsidiary of Pfizer28
Active, not recruiting
Not Applicable
A randomised, double-blind, four way cross-over, placebo controlled trial to evaluate the clinical efficacy, onset of action and drug activity at 22-26 hours following the drug intake of Bilastne 20 mg vs placebo and in competition to Cetirizine 10 mg, Fexofenadine 120 mg in reducing symptoms of seasonal allergic rhinitis in grass pollen sensitized volunteers exposed on 2 consecutive days in the Vienna Challenge ChamberEUCTR2006-003004-19-ATFAES Farma S.A.76
Completed
Phase 4
A clinical study on Pentavalent vaccineCTRI/2009/091/000375Serum Institute Of India Ltd600
Recruiting
Not Applicable
The effects of the antihistamine bilastine on actual driving performance.allergic rhinitisSedationantihistamineBilastineNL-OMON27203FAES FARMA S.A.20